DRUGGING THE UNDRUGGABLE®
for the next generation of therapies
How we are expanding druggable space
PhoreMost is applying its proprietary SITESEEKER® technology to drive the discovery of tomorrow’s medicines
We are advancing a pipeline of novel targets in oncology and Targeted Protein Degradation (TPD)
View our pipeline and learn more about SITESEEKER®We collaborate with a wide range of industry partners to develop ground-breaking medicines against challenging diseases
Find out more about partnering with us
News
Blog
PhoreMost appoints Professor Peter Parker and Dr Jason Imbriglio to Scientific Advisory Board
17th July 2023
Blog